Sebastian Drube
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi-Drug-Resistant Protein MDR1 (ABCB1) in Mast Cells.
Journal: Immunology
Published: July 11, 2025
Age- and sex-associated differences in immune cell populations.
Journal: iScience
Published: October 25, 2024
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?
Journal: Frontiers in immunology
Published: October 15, 2022
The Heat Shock Protein 90 (HSP90) Is Required for the IL-33-Induced Cytokine Production in Mast Cells (MCs).
Journal: International journal of molecular sciences
Published: August 19, 2022
Interleukin-3 stabilizes CD124/IL-4α surface expression in mast cells via Tyk2 and STAT6.
Journal: Immunology
Published: October 28, 2021
Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.
Journal: Cell chemical biology
Published: April 07, 2021
ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids.
Journal: Immunology
Published: February 22, 2021
Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma.
Journal: PloS one
Published: November 30, 2020
IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced RORγt+ Treg generation via enhanced IL-6 induction.
Journal: Immunology
Published: July 08, 2020
Last Updated: 09/26/2026